Eye movement therapy for long-term itching
Part of Skin clinical trials.
This study tests a type of therapy called EMDR, which uses eye movements to help your brain process feelings, to see if it can reduce chronic itching. If you join, you might find relief from your itch without more pills or creams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had itchy skin for at least 6 weeks (chronic pruritus)
- Your itching is at least a 4 on a 0-10 scale in the last week
- Your treatment has been stable for the last 2 weeks (no changes)
- You are not currently having light therapy (phototherapy) and have no severe heart disease or recent autoimmune flare-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial sets up a patient library for people who have itching with no clear underlying skin or medical cause. It aims to collect patient input and experiences to improve understanding and support for this condition.
This study is a registry, which means it collects information about people with chronic itching. By joining, you help researchers learn more about different causes and treatments of chronic itch, with no extra tests or medicines.
This study tests a light-based therapy (called photobiomodulation) to see if it can reduce itch. The treatment uses a special light on the skin, which may help calm the nerves or cells that cause itching. You'll have one side of your body treated and the other side not, so the researchers can compare the effects.
This trial tests whether combining hypnosis with virtual reality can reduce chronic itch. It may help if you have had itching for at least a year, seen a doctor for it, and it still affects your daily life despite treatment.
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.
Hear when a new Chronic Pruritus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.